Live feed
Filing
SC 13G
SC 13G0001193125-21-321770·Bain Capital Life Sciences Fund II, L.P.
Schedule 13G ownership disclosure
XILIO THERAPEUTICS INC
Security class unavailable · CUSIP: 98422T100
Event date: 2021-10-26
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 5.1000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001193125-21-321770
- Form type
- SC 13G
- Filer
- Bain Capital Life Sciences Fund II, L.P.
- CIK
- CIK 1773187
- Filed
- Nov 05, 2021
- Reporting period
- Oct 26, 2021
- Description
- Schedule 13G beneficial ownership